InsidersTradesSigma
HEM파마 Stock: price and management transactions · South Korea · DART (FSS)
Follow the HEM파마 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, HEM파마 has recorded 26 insider filings. Market capitalisation: €293.9bn. The latest transaction was reported on 22 June 2026 (Other). Among the most active insiders: 지요셉. Every trade is accessible without an account.
26
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
2 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,584 of 26,211 companies
10.7
score / 100
Value19
Quality3
FCF yld-6.3%
Earn yld-8.2%
EV/EBITDA·
ROE-194%
Gross mgn4.9%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 June 2026
Declarations26 total
25 of 26 declarations
About HEM파마
HEM파마 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.